DEA Should Allow Psychedelic Therapy, 9th Circ. Told

By Sam Reisman (July 26, 2021, 8:30 PM EDT) -- The U.S. Drug Enforcement Administration has a responsibility to allow the use of Schedule I substances such as psychedelics for specific, medicinal purposes, a group of patients told the Ninth Circuit on Friday.

According to the patients' reply brief, the Controlled Substances Act must give way to a 2018 federal "Right to Try" law and similar state laws that allow eligible patients to use drugs that have not been approved by federal regulators.

Furthermore, the patients argued, the DEA's inflexibility on the issue makes it ripe for judicial review, despite the agency's pleadings that it had not rendered a final and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!